D-0390-2025 Class II Ongoing

Recalled by Eugia US LLC — East Windsor, NJ

Recall Details

Product Type
Drugs
Report Date
May 7, 2025
Initiation Date
April 21, 2025
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01

Reason for Recall

Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.

Distribution Pattern

USA nationwide.

Code Information

Lot# : 3TF24001, Exp 3/31/2026